Cargando…
Variability in detection of SARS-CoV-2-specific antibody responses following mild infection: a prospective multicentre cross-sectional study, London, United Kingdom, 17 April to 17 July 2020
INTRODUCTION: Immunoassays targeting different SARS-CoV-2-specific antibodies are employed for seroprevalence studies. The degree of variability between immunoassays targeting anti-nucleocapsid (anti-NP; the majority) vs the potentially neutralising anti-spike antibodies (including anti-receptor-bin...
Autores principales: | Pallett, Scott JC, Jones, Rachael, Abdulaal, Ahmed, Pallett, Mitchell A, Rayment, Michael, Patel, Aatish, Denny, Sarah J, Mughal, Nabeela, Khan, Maryam, Rosadas de Oliveira, Carolina, Pantelidis, Panagiotis, Randell, Paul, Toumazou, Christofer, O’Shea, Matthew K, Tedder, Richard, McClure, Myra O, Davies, Gary W, Moore, Luke SP |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796290/ https://www.ncbi.nlm.nih.gov/pubmed/35086612 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.4.2002076 |
Ejemplares similares
-
Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation
por: Pallett, Scott J. C., et al.
Publicado: (2023) -
Testing for responses to the wrong SARS-CoV-2 antigen?
por: Rosadas, Carolina, et al.
Publicado: (2020) -
Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
por: Pallett, Scott JC., et al.
Publicado: (2021) -
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay
por: Pallett, Scott J.C., et al.
Publicado: (2022) -
Characterising differential antibody response is integral to future SARS-CoV-2 serostudies
por: Pallett, Scott John Charles, et al.
Publicado: (2020)